The Company expects its addressable markets will expand from $84 billion in 2021 to $102 billion by 2025. The company invests more than $1 billion in R&D annually and generates approximately $18 billion in revenue across its four business segments – Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/KIZPDjY
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» GE HealthCare completes spin-off, begins trading on Nasdaq
https://ift.tt/B7mQ34R
No comments:
Post a Comment